Association Between Industry Marketing Payments and Prescriptions for PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibitors in the United States.

Inoue, Kosuke; Figueroa, Jose F; DeJong, Colette; Tsugawa, Yusuke; Orav, E John; Shen, Changyu; Kazi, Dhruv S

Inoue, Kosuke; Figueroa, Jose F; DeJong, Colette; Tsugawa, Yusuke; Orav, E John; Shen, Changyu; Kazi, Dhruv S.

Affiliation

Inoue K; Department of Epidemiology (K.I.) UCLA Fielding School of Public Health.
Figueroa JF; Department of Social Epidemiology, Graduate School of Medicine, Kyoto University, Kyoto, Japan (K.I.).
DeJong C; Department of Health Policy and Management (J.F.F., E.J.O.) Harvard T.H. Chan School of Public Health, Boston, MA.
Tsugawa Y; Department of Medicine, Brigham and Women's Hospital, Boston, MA (J.F.F.).
Orav EJ; Department of Medicine, University of California, San Francisco School of Medicine (C.D.).
Shen C; Department of Health Policy and Management (Y.T.), UCLA Fielding School of Public Health.
Kazi DS; Division of General Internal Medicine and Health Services Research, David Geffen School of Medicine at UCLA (Y.T.).

Circ Cardiovasc Qual Outcomes ; 14(5): e007521, 2021 05.

Article in En | MEDLINE | ID: mdl-33966446

Subject(s)

Medicare; Proprotein Convertase 9; Aged; Humans; Marketing; Prescriptions; Subtilisins; United States

Key words

Medicare; United States; marketing; prescription; prior authorization

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Medicare / Proprotein Convertase 9 Type of study: Prognostic_studies / Risk_factors_studies Limits: Aged / Humans Country/Region as subject: America do norte Language: En Journal: Circ Cardiovasc Qual Outcomes Journal subject: ANGIOLOGIA / CARDIOLOGIA Year: 2021 Document type: Article Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google